Header Logo

MARY MCKENNA

TitleInstructor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address6621 FANNIN
Houston, TX 77030
vCardDownload vCard
    Other Positions
    TitleInstructor
    InstitutionBaylor College of Medicine
    DepartmentCenter for Cell & Gene Therapy
    DivisionCenter for Cell & Gene Therapy


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Torres Chavez AG, McKenna MK, Balasubramanian K, Riffle L, Patel NL, Kalen JD, St Croix B, Leen AM, Bajgain P. A dual-luciferase bioluminescence system for the assessment of cellular therapies. Mol Ther Oncol. 2024 Mar 21; 32(1):200763. PMID: 38596291; PMCID: PMC10869576.
      Citations:    
    2. McKenna MK, Ozcan A, Brenner D, Watanabe N, Legendre M, Thomas DG, Ashwood C, Cummings RD, Bonifant C, Markovitz DM, Brenner MK. Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma. J Immunother Cancer. 2023 01; 11(1). PMID: 36653070; PMCID: PMC9853244.
      Citations:    Fields:    Translation:HumansAnimalsCells
    3. Watanabe N, Mo F, McKenna MK. Impact of Manufacturing Procedures on CAR T Cell Functionality. Front Immunol. 2022; 13:876339. PMID: 35493513; PMCID: PMC9043864.
      Citations: 1     Fields:    Translation:HumansCells
    4. Atilla PA, McKenna MK, Watanabe N, Mamonkin M, Brenner MK, Atilla E. Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancy. Cytotherapy. 2022 03; 24(3):282-290. PMID: 34955406; PMCID: PMC8950815.
      Citations:    Fields:    Translation:AnimalsCellsCTClinical Trials
    5. Nalawade SA, Shafer P, Bajgain P, McKenna MK, Ali A, Kelly L, Joubert J, Gottschalk S, Watanabe N, Leen A, Parihar R, Vera Valdes JF, Hoyos V. Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer. J Immunother Cancer. 2021 11; 9(11). PMID: 34815355; PMCID: PMC8611441.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    6. Watanabe N, McKenna MK. Generation of CAR T-cells using ?-retroviral vector. Methods Cell Biol. 2022; 167:171-183. PMID: 35152995; PMCID: PMC8917789.
      Citations: 1     Fields:    Translation:Cells
    7. Rosewell Shaw A, Porter CE, Yip T, Mah WC, McKenna MK, Dysthe M, Jung Y, Parihar R, Brenner MK, Suzuki M. Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors. Commun Biol. 2021 03 19; 4(1):368. PMID: 33742099; PMCID: PMC7979740.
      Citations: 7     Translation:HumansCells
    8. McKenna MK, Englisch A, Brenner B, Smith T, Hoyos V, Suzuki M, Brenner MK. Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity. Mol Ther. 2021 05 05; 29(5):1808-1820. PMID: 33571680; PMCID: PMC8116608.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    9. Watanabe N, McKenna MK, Rosewell Shaw A, Suzuki M. Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment. Mol Ther. 2021 02 03; 29(2):505-520. PMID: 33130314; PMCID: PMC7854303.
      Citations: 8     Fields:    Translation:HumansCells
    10. Ataca Atilla P, McKenna MK, Tashiro H, Srinivasan M, Mo F, Watanabe N, Simons BW, McLean Stevens A, Redell MS, Heslop HE, Mamonkin M, Brenner MK, Atilla E. Modulating TNFa activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. J Immunother Cancer. 2020 09; 8(2). PMID: 32938629; PMCID: PMC7497527.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    11. Mo F, Watanabe N, McKenna MK, Hicks MJ, Srinivasan M, Gomes-Silva D, Atilla E, Smith T, Ataca Atilla P, Ma R, Quach D, Heslop HE, Brenner MK, Mamonkin M. Engineered off-the-shelf therapeutic T cells resist host immune rejection. Nat Biotechnol. 2021 01; 39(1):56-63. PMID: 32661440; PMCID: PMC7854790.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    12. McKenna MK, Rosewell-Shaw A, Suzuki M. Modeling the Efficacy of Oncolytic Adenoviruses In Vitro and In Vivo: Current and Future Perspectives. Cancers (Basel). 2020 Mar 07; 12(3). PMID: 32155969; PMCID: PMC7139921.
      Citations: 4     
    13. Torres Chavez A, McKenna MK, Canestrari E, Dann CT, Ramos CA, Lulla P, Leen AM, Vera JF, Watanabe N. Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity. J Immunother Cancer. 2019 11 28; 7(1):330. PMID: 31779709; PMCID: PMC6883585.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    MCKENNA's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (72)
    Explore
    _
    Co-Authors (18)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _